ENO2 and nonpapillary renal cell carcinoma: Functional and mechanistic investigations have corroborated that ENO2 is transcriptionally activated by HIF-1α, and it orchestrates tumor cell glycolysis to sustain the energy supply and promote the progression of ccRCC.